Invesco Biotechnology & Genome ETF
PBE
#2065
ETF Rang
€0.24 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
78,59 €
Aktienkurs
-0.38%
Veränderung (1 Tag)
40.32%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 23. Juli 2026Anzahl der Bestände: 33

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
5.00%
Amgen IncAMGN38102
4.96%
Royalty Pharma PLCRPRX237665
4.91%
Vertex Pharmaceuticals IncVRTX29366
4.70%
Biogen IncBIIB66296
4.65%
Regeneron Pharmaceuticals IncREGN20169
4.43%
Gilead Sciences IncGILD95721
4.31%
CareDx IncCDNA324147
4.14%
United Therapeutics CorpUTHR22127
4.12%
Alnylam Pharmaceuticals IncALNY43319
3.69%
Bio-Techne CorpTECH145555
3.35%
Illumina IncILMN48078
3.34%
Protagonist Therapeutics IncPTGX69833
3.23%
Veracyte IncVCYT157932
3.18%
Vericel CorpVCEL199662
2.97%
Incyte CorpINCY71907
2.95%
Repligen CorpRGEN60614
2.90%
Halozyme Therapeutics IncHALO101605
2.88%
ACADIA Pharmaceuticals IncACAD328418
2.88%
QIAGEN NVQGEN196461.3786
2.86%
PTC Therapeutics IncPTCT103212
2.76%
Neurocrine Biosciences IncNBIX44836
2.75%
Exelixis IncEXEL139699
2.75%
BioMarin Pharmaceutical IncBMRN132040
2.73%
BioCryst Pharmaceuticals IncBCRX824338
2.60%
Collegium Pharmaceutical IncCOLL206694
2.35%
Sarepta Therapeutics IncSRPT418846
2.35%
AnaptysBio IncANAB120862
2.18%
Omeros CorpOMER599328
2.03%
Ardelyx IncARDX1117146
1.97%
Legend Biotech CorpLEGN236443
0.08%
Invesco Government & Agency PortfolioAGPXX218839.77
0.00%
CASH & EQUIVALENTSUSD5731.72
0.00%
USD Pending Dividends0